Unknown

Dataset Information

0

Rational antibody design for undruggable targets using kinetically controlled biomolecular probes.


ABSTRACT: Several important drug targets, e.g., ion channels and G protein-coupled receptors, are extremely difficult to approach with current antibody technologies. To address these targets classes, we explored kinetically controlled proteases as structural dynamics-sensitive druggability probes in native-state and disease-relevant proteins. By using low-Reynolds number flows, such that a single or a few protease incisions are made, we could identify antibody binding sites (epitopes) that were translated into short-sequence antigens for antibody production. We obtained molecular-level information of the epitope-paratope region and could produce high-affinity antibodies with programmed pharmacological function against difficult-to-drug targets. We demonstrate the first stimulus-selective monoclonal antibodies targeting the transient receptor potential vanilloid 1 (TRPV1) channel, a clinically validated pain target widely considered undruggable with antibodies, and apoptosis-inducing antibodies selectively mediating cytotoxicity in KRAS-mutated cells. It is our hope that this platform will widen the scope of antibody therapeutics for the benefit of patients.

SUBMITTER: Trkulja CL 

PROVIDER: S-EPMC8051879 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC3199569 | biostudies-literature
| S-EPMC7179085 | biostudies-literature
| S-EPMC7453994 | biostudies-literature
| S-EPMC3944097 | biostudies-literature
| S-EPMC10013958 | biostudies-literature
| S-EPMC8826573 | biostudies-literature
| S-EPMC3232316 | biostudies-literature
| S-EPMC4046760 | biostudies-literature
| S-EPMC7184884 | biostudies-literature
| S-EPMC4609572 | biostudies-literature